BioFuture Notebook: State Of Industry Seen As ‘Bewildering,’ ‘Confusing’ And ‘Uncertain’

 
• By Alaric DeArment
  
Sara Jane Demy interviews James Flynn in a fireside chat to kick off BioFuture 2025. (Alaric DeArment/Alaric DeArment)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Conferences

More from Scrip